Scientists in Liverpool have found evidence to suggest that certain genetic mutations are key in determining how children with brain tumours will respond to chemotherapy.
The SDBTT-funded research has been published in peer-reviewed science journal Cell Death & Disease, and could lead to improved treatment options for children affected by medulloblastoma, the most common childhood brain tumour type.
See the full press release and journal article to find out more.